Trial Profile
A Cross-sectional REVEAL Sub-study Evaluating the Effect of Anacetrapib on Vascular Function and Arterial Stiffness [An Investigator Led Sub-study of HPS3/TIMI 55: REVEAL]
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Anacetrapib (Primary) ; Atorvastatin
- Indications Cardiovascular disorders; Vascular disorders
- Focus Therapeutic Use
- Acronyms REVEAL-Vasc
- 15 Aug 2018 Status changed from recruiting to completed.
- 23 Jun 2017 Planned number of patients changed from 90 to 130.
- 10 Jan 2017 Status changed from not yet recruiting to recruiting.